The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension
Open accessAbstract
BACKGROUND: Oxidative stress has been proposed as a mechanism linking the poor placental perfusion characteristic of preeclampsia with the clinical manifestations of the disorder. We assessed the effects of antioxidant supplementation with vitamins C and E, initiated early in pregnancy, on the risk of serious adverse maternal, fetal, and neonatal outcomes related to pregnancy-associated hypertension. METHODS: We conducted a multicenter, randomized, double-blind trial involving nulliparous women who were at low risk for preeclampsia. Women were randomly assigned to begin daily supplementation with 1000 mg of vitamin C and 400 IU of vitamin E or matching placebo between the 9th and 16th weeks of pregnancy. The primary outcome was severe pregnancy-associated hypertension alone or severe or mild hypertension with elevated liver-enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, medically indicated preterm birth, fetal-growth restriction, or perinatal death. RESULTS: A total of 10,154 women underwent randomization. The two groups were similar with respect to baseline characteristics and adherence to the study drug. Outcome data were available for 9969 women. There was no significant difference between the vitamin and placebo groups in the rates of the primary outcome (6.1% and 5.7%, respectively; relative risk in the vitamin group, 1.07; 95% confidence interval [CI], 0.91 to 1.25) or in the rates of preeclampsia (7.2% and 6.7%, respectively; relative risk, 1.07; 95% CI, 0.93 to 1.24). Rates of adverse perinatal outcomes did not differ significantly between the groups. CONCLUSIONS: Vitamin C and E supplementation initiated in the 9th to 16th week of pregnancy in an unselected cohort of low-risk, nulliparous women did not reduce the rate of adverse maternal or perinatal outcomes related to pregnancy-associated hypertension (ClinicalTrials.gov number, NCT00135707).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Chappell, L. C., Seed, P. T., Briley, A. L., Kelly, F. J., Lee, R., Hunt, B. J., Parmar, K., Bewley, S. J., Shennan, A. H., Steer, P. J., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80010-5 · Cited by 786
Poston, L., Briley, A., Seed, P., Kelly, F., & Shennan, A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68433-x · Cited by 760
Oxidative Stress in the Pathogenesis of Preeclampsia
Hubel, C. A. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-139.x · Cited by 676
Placental oxidative stress: from miscarriage to preeclampsia
Burton, G. J., & Jauniaux, E. (2004) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2004.03.003 · Cited by 673
Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis
Carey, J. C., Klebanoff, M. A., Hauth, J. C., Hillier, S. L., Thom, E. A., Ernest, J. M., Heine, R. P., Nugent, R. P., Fischer, M. L., Leveno, K. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420802 · Cited by 673
Self-citationPrevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women
Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291701 · Cited by 558
Self-citationVitamins C and E and the Risks of Preeclampsia and Perinatal Complications
Rumbold, A. R., Crowther, C. A., Haslam, R. R., Dekker, G. A., & Robinson, J. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054186 · Cited by 472
Buchbinder, A., Sibai, B. M., Caritis, S., MacPherson, C., Hauth, J., Lindheimer, M. D., Klebanoff, M., VanDorsten, P., Landon, M., Paul, R., et al. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.120080 · Cited by 373
Self-citationA longitudinal study of biochemical variables in women at risk of preeclampsia
Chappell, L. C., Seed, P. T., Briley, A., Kelly, F. J., Hunt, B. J., Charnock-Jones, D. S., Mallet, A. I., & Poston, L. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.122969 · Cited by 355
Hubel, C. A., McLaughlin, M. K., Evans, R. W., Hauth, B. A., Sims, C. J., & Roberts, J. M. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70336-8 · Cited by 301
Self-citationRandomization in clinical trials: Conclusions and recommendations
Lachin, J. M., Matts, J. P., & Wei, L. J. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90049-9 · Cited by 272
Alexander, G. R., Kogan, M. D., & Himes, J. H. (1999) · Maternal and Child Health Journal · doi:10.1023/a:1022381506823 · Cited by 250
Prevention of Preeclampsia With Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women
Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M., et al. (1994) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199404000-00002 · Cited by 249
Self-citationEvidence for Peroxynitrite Formation in the Vasculature of Women With Preeclampsia
Roggensack, A. M., Zhang, Y., & Davidge, S. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.83 · Cited by 227
Villar, J., Purwar, M., Merialdi, M., Zavaleta, N., thi Nhu Ngoc, N., Anthony, J., De Greeff, A., Poston, L., Shennan, A., & on behalf of the WHO Vitamin C and Vitamin E trial group (2009) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02158.x · Cited by 204
Antioxidant Therapy to Prevent Preeclampsia: A Randomized Controlled Trial
Spinnato, J. A., Freire, S., Pinto e Silva, J. L., Cunha Rudge, M. V., Martins-Costa, S., Koch, M. A., Goco, N., Santos, C. D. B., Cecatti, J. G., Costa, R., et al. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000289576.43441.1f · Cited by 161
Proteinuria and its assessment in normal and hypertensive pregnancy
Kuo, V. S., Koumantakis, G. A., & Gallery, E. D. M. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91578-6 · Cited by 144
Protein Carbonyls in Decidua and Placenta of Pre-eclamptic Women as Markers for Oxidative Stress
Zusterzeel, P. L. M., Rütten, H., Roelofs, H. M. J., Peters, W. H. M., & Steegers, E. A. P. (2001) · Placenta · doi:10.1053/plac.2000.0606 · Cited by 138
No evidence for lipid peroxidation in severe preeclampsia
Regan, C. L., Levine, R. J., Baird, D. D., Ewell, M., Martz, K. L., Sibai, B. M., Rokach, J., Lawson, J. A., & FitzGerald, G. A. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.116754 · Cited by 89
METRONIDAZOLE TO PREVENT PRETERM DELIVERY IN PREGNANT WOMEN WITH ASYMPTOMATIC BACTERIAL VAGINOSIS
Hristopher, J. C., Lebanoff, M. A. K., Auth, J., Illier, S. H. L. H., Hom, E., Hillip, R. P., Ugent, R. O. P. N., Ischer, M. O. L. F., Enneth, K., Eveno, J. L., et al. (2007) · Cited by 84
Protein/Creatinine Ratio in Preeclampsia
Papanna, R. M., Mann, L. K., Kouides, R. W., et al. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181778cfc · Cited by 74
Oxidative DNA damage in placentas from normal and pre-eclamptic pregnancies
Wiktor, H., Kankofer, M., Schmerold, I., Dadak, A. M., Łopucki, M., & Niederm�ller, H. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1024-2 · Cited by 59
Placental Anti-Oxidant Gene Polymorphisms, Enzyme Activity, and Oxidative Stress in Preeclampsia
Zhang, J., Masciocchi, M., Lewis, D. A., Sun, W., Liu, A., & Wang, Y. (2008) · Placenta · doi:10.1016/j.placenta.2008.02.012 · Cited by 38
Antioxidant Therapy to Prevent Preeclampsia: A Randomized Controlled Trial
Spinnato, J. A., Freire, S., Silva, J. L. P. E., Rudge, M. V. C., Martins-Costa, S., Koch, M. A., Goco, N. J., Santos, B. B., Cecatti, J. G., Costa, R., et al. (2008) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000326403.82767.29 · Cited by 32
Vitamins C and E and the Prevention of Preeclampsia
Briley, A. L., Poston, L., & Shennan, A. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmc061414 · Cited by 22
Cited by
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
The effects of oxidative stress on female reproduction: a review
Agarwal, A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A., & Gupta, S. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-49 · Cited by 1,637
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Vitamins C and E: Beneficial effects from a mechanistic perspective
Traber, M. G., & Stevens, J. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.017 · Cited by 1,076
Burton, G. J., & Jauniaux, E. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.016 · Cited by 988
Metadata
- Authors
- Roberts, J. M., Myatt, L., Spong, C. Y., Thom, E. A., Hauth, J. C., Leveno, K. J., Pearson, G. D., Wapner, R. J., Varner, M. W., Thorp, J. M., Mercer, B. M., Peaceman, A. M., Ramin, S. M., Carpenter, M. W., Samuels, P., Sciscione, A., Harper, M., Smith, W. J., Saade, G., Sorokin, Y., & Anderson, G. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-08
- Volume
- 362
- Issue
- 14
- Pages
- 1282-1291
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2167559287
- Cited by
- 402
- References
- 27
- FWCI
- 50.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.